MarketsStocksMARKSANS
MA

MARKSANS PHARMA

NSE: MARKSANSBSE: 524404Healthcare
Download Research Report7-page PDF
236.00
+1.21%
NSE · auto-updates while market open
Prev Close
₹251.95
Day High
₹241.91
Day Low
₹228.20
Mkt Cap
₹10,961 Cr
P / E
26.1
P / B
3.6
ROE
25.7%
52W High
₹270.70
52W Low
₹155.00
Key Metrics
Market Cap
₹10,961 Cr
P / E
26.10
P / B
3.63
EV / EBITDA
15.99
ROCE
35.4%
ROE
25.7%
Debt / Equity
0.01
Book Value
₹66.71
EPS
₹9.22
Div Yield
0.3%
Face Value
₹1
Promoter Holding
43.9%
Revenue · ₹ Cr
1.1k
FY20
1.4k
FY21
1.5k
FY22
1.9k
FY23
2.2k
FY24
262
FY25
3.0k
FY26
Net Profit · ₹ Cr
121
FY20
239
FY21
187
FY22
265
FY23
315
FY24
38
FY25
420
FY26
EPS · ₹ per share
₹2.9
FY20
₹5.8
FY21
₹4.5
FY22
₹6.4
FY23
₹6.9
FY24
₹8.4
FY25
₹9.2
FY26
P / E Ratio · price ÷ TTM EPS
32138551150-1Jun 21Feb 23Oct 24Jun 26
P/E 25.6×Median 19.6×TTM EPS
Q1 2026 snapshot
Sales
₹891 Cr
Operating profit
-
OPM
-
Net profit
₹149 Cr
EPS
₹3.27
Scorecard · 7 axes
Quality
Strong
100/100
Valuation
Avg
26.1×
Growth
Strong
+20.5%
Profitability
Strong
30.6%
Performance
Bad
-9.6%
Entry Point
Avg
87%
Red Flags
Strong
0 flags
Shareholding Pattern
43.9%Promoter
Promoter43.9%
FII16.8%
DII6.6%
Public32.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue68272.5625.63741.98774.57891.29
Net Profit1059.07358.20299.139113.69149.032
NPM %15.4%12.5%9.3%13.4%14.7%16.7%
AlertPre-trade